At the time of writing, Insmed Inc [INSM] stock is trading at $3000000.0, up 4668925%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The INSM shares have gain 5.99% over the last week, with a monthly amount glided 49.88%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on May 13, 2025, when Jefferies initiated its Buy rating and assigned the stock a price target of $105. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on February 25, 2025, and set its price target to $100. On April 23, 2024, Truist initiated with a Buy rating and assigned a price target of $48 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $42 on February 15, 2024. Wells Fargo initiated its recommendation with a Overweight and recommended $55 as its price target on December 08, 2023. In a note dated July 26, 2023, Guggenheim initiated an Buy rating and provided a target price of $50 on this stock.
For the past year, the stock price of Insmed Inc fluctuated between $60.40 and $102.00. Currently, Wall Street analysts expect the stock to reach $110 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $3000000.0 at the most recent close of the market. An investor can expect a potential drop of -100.0% based on the average INSM price forecast.
Analyzing the INSM fundamentals
According to Insmed Inc [NASDAQ:INSM], the company’s sales were 381.03M for trailing twelve months, which represents an 22.94% jump. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at -2.3%, Pretax Profit Margin comes in at -2.65%, and Net Profit Margin reading is -2.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.56, Equity is -4.47 and Total Capital is -0.56. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of11.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Insmed Inc [NASDAQ:INSM] has a current ratio of 5.86. In addition, the Quick Ratio stands at 5.44 and the Cash Ratio stands at 1.69. Considering the valuation of this stock, the price to sales ratio is 51.19, the price to book ratio is 188.36.
Transactions by insiders
Recent insider trading involved Lewis William, Chair and CEO, that happened on Jun 16 ’25 when 0.13 million shares were sold. Chair and CEO, Lewis William completed a deal on Jun 16 ’25 to sell 5204.0 shares. Meanwhile, Chief Operating Officer Adsett Roger sold 10686.0 shares on Jun 16 ’25.
